v3.26.1
Consolidated Statements of Cash Flows (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities        
Net increase (decrease) in net assets resulting from operations $ 32,205,000 $ 23,616,000 $ 56,906,000 $ 66,171,000
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:        
Amortization of deferred debt issuance costs 983,000 1,149,000 2,945,000 3,070,000
Amortization of deferred offering costs 0 0 0 68,000
Accretion of discounts and amortization of premiums     (5,171,000) (3,722,000)
Net realized (gain) loss on investments (1,319,000) 0 (1,319,000) 0
Net realized (gain) loss on foreign currency transactions 139,000 214,000 (355,000) (67,000)
Net change in unrealized (appreciation) depreciation on investments (49,000) (369,000) 35,756,000 (4,060,000)
Net change in unrealized (appreciation) depreciation on forward currency contracts (62,000) 807,000 (361,000) 966,000
Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies (87,000) (1,147,000) 606,000 (668,000)
Proceeds from (fundings of) revolving loans, net     (15,684,000) (5,697,000)
Fundings of investments     (643,075,000) (636,176,000)
Proceeds from principal payments and sales of portfolio investments     179,756,000 81,694,000
Payment-in-kind interest capitalized (4,047,000) (2,412,000) (11,390,000) (6,973,000)
Non-cash dividends capitalized     (711,000) (387,000)
Proceeds from non-cash dividends     111,000 170,000
Changes in operating assets and liabilities:        
Interest receivable     798,000 (978,000)
Receivable for investments     (846,000) 4,247,000
Other assets     36,000 (636,000)
Interest payable     (3,265,000) (1,809,000)
Management and income incentive fees payable     851,000 1,121,000
Payable for investments purchased     10,000 0
Accrued trustee fees     63,000 5,000
Accounts payable and other liabilities     (1,178,000) 566,000
Net cash provided by (used in) operating activities     (405,517,000) (503,095,000)
Cash flows from financing activities        
Borrowings on debt     646,613,000 2,163,314,000
Repayments of debt     (336,378,000) (1,667,345,000)
Capitalized debt issuance costs     (28,000) (4,521,000)
Proceeds from issuance of common shares     147,671,000 332,667,000
Distributions paid     (48,235,000) (51,995,000)
Net cash provided by (used in) financing activities     409,643,000 772,120,000
Net change in cash, cash equivalents, foreign currencies, restricted cash, restricted cash equivalents and restricted foreign currencies     4,126,000 269,025,000
Effect of foreign currency exchange rates     300,000 (995,000)
Cash, cash equivalents, foreign currencies, restricted cash, restricted cash equivalents and restricted foreign currencies, beginning of period     66,307,000 [1] 34,847,000
Cash, cash equivalents, foreign currencies, restricted cash, restricted cash equivalents and restricted foreign currencies, end of period 70,733,000 [1] 302,877,000 70,733,000 [1] 302,877,000
Supplemental disclosure of cash flow information:        
Cash paid during the period for interest     59,070,000 44,727,000
Distributions declared for the period $ 56,906,000 $ 66,171,000 56,906,000 66,171,000
Supplemental disclosure of non-cash operating and financing activity:        
Change in capital call receivable     (94,000) 68,000
Stock issued in connection with dividend reinvestment plan     11,829,000 13,030,000
Change in distributions payable     $ (3,158,000) $ 1,146,000
[1] See Note 2 for a description of cash, cash equivalents, foreign currencies, restricted cash, restricted cash equivalents and restricted foreign currencies.